SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-007861
Filing Date
2022-04-01
Accepted
2022-04-01 16:52:45
Documents
2
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 11845
2 EXPLANATION OF RESPONSES i040122.htm EX-99.1 6874
  Complete submission text file 0001567619-22-007861.txt   21288
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Issuer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Reporting) CIK: 0001080014 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37544 | Film No.: 22799070
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1209 ORANGE STREET WILMINGTON DE 19801
Business Address 1209 ORANGE STREET WILMINGTON DE 19801 877 202 1097
Innoviva Strategic Opportunities LLC (Reporting) CIK: 0001842875 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37544 | Film No.: 22799069